back to top
Thursday, 12 June, 2025
HomeHepatology

Hepatology

Study to look at new ARV tx for HCV

The US National Institutes of Health has launched a clinical trial to examine whether primary care physicians, nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection alone, or co-infected with HIV.

Immunosuppressants may re-activate HBV

Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a Saint Louis University study.

Erectile dysfunction drugs to treat liver sepsis

Drugs to treat erectile dysfunction might be able to protect the liver from damage caused by sepsis, according to University of Pittsburgh researchers on mice.

Study reverses thought on cirrhotic patients with type 2 diabetes

Researchers at Mayo Clinic have released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. News-Medical reports...